Free

Biomarkers & biotherapies in heart & kidney failure: from France to Japan

Actions and Detail Panel

Free

Event Information

Share this event

Date and time

Location

Location

Online event

Event description
Scientific panel discussions on ZOOM / Two-week trip to Japan in 2021 financed by Inserm for 2 French fellows (under 45)

About this event


		Biomarkers & biotherapies in heart & kidney failure:  from France to Japan image

Please note that this event wil take place on ZOOM , a link will be sent out to the registered people 2 days before the seminar.

An in person event is organised in Paris at Lariboisière Hospital (2 rue Ambroisé Paré; 75010 Paris): practical information about the venue will be available soon.


		Biomarkers & biotherapies in heart & kidney failure:  from France to Japan image

The aim of the seminar is to explore geographical differences between Asia and Europe in order to better understand the development and clinical validation of therapeutic innovation, possibly based on biomarker-guided therapies, or even biotherapies in the field of acute heart and kidney failure.

In order to promote scientific cooperations between France and Japan, Inserm will finance a two-week trip to Japan in 2021 for 2 French researchers under the age of 45 and working in the cardiovascular or renal area . If you are interested, please send an e-mail to carole.breviere@aphp.fr for more information. Applications deadline : September the 10th.

Seminar Agenda:

(8:30 am -8:45) Introduction

  • Speakers: Prof. Naoki Sato/ Prof. Alexandre Mebazaa / Hugues Boiteau (Inserm)/ Prof Catherine Chaussain (University of Paris)

(8:45-9:25) Session 1: Epidemiology and mechanisms of heart failure / Chaired by Dr. Shiro Ishihara & Prof. Etienne Gayat

  1. Why heart failure related outcomes are different between Asia and Europe? (Dr. Eichii Hideo)
  2. Differences in drug trials results between Europe and Asia (Prof. Faiez Zannad)
  3. Ischemia (Dr. Hideo Tokuyama)
  4. Congestion (Prof. Naoki Sato)

(9:25-10:00) Q&A

(10:00-10:15) Break

(10:15-10:55) Session 2: From biomarkers to biotherapies in heart and kidney / Chaired by Dr. Kento Doi & Dr Chantal Boulanger (to be confirmed)

  1. How heart failure is damaging the kidney? (speaker to be confirmed)
  2. The role of Galectin-3 in kidney failure-related heart dysfunction (Dr. François Depret)
  3. L- Fatty Acid-Binding Protein (FABP) (Dr. Shiro Ishihara )
  4. Circulating dipeptidyl peptidase 3: new hope for cardiogenic shock? (Dr. Alice Blet)

(10:55-11:30) Q&A

(11:30-11:45) Break

(11:45-1:15) Session 3: Young fellows on stage

Jury: Dr Jean-Sébastien Silvestre/ Prof. Shibagaki/Dr. Jane-lise Samuel/ Dr Olivia Lenoir

  1. Contestants' pitch
  2. Jury deliberations and announcement of the two winners

(1:15-1:30) Conclusion of the session

  • Speakers: Prof. Naoki Sato/ Prof. Alexandre Mebazaa

Share with friends

Date and time

Location

Online event

Organiser Inserm

Organiser of Biomarkers & biotherapies in heart & kidney failure: from France to Japan

Save This Event

Event Saved